Simplex Trading’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $796K | Buy |
54,589
+47,053
| +624% | +$454K | ﹤0.01% | 3031 |
|
|
2026
Q1 | $55.9K | Sell |
7,536
-7,155
| -49% | -$75.3K | ﹤0.01% | 5748 |
|
|
2025
Q4 | $173K | Sell |
14,691
-9,071
| -38% | -$97.9K | ﹤0.01% | 4375 |
|
|
2025
Q3 | $183K | Buy |
23,762
+686
| +3% | +$4.8K | ﹤0.01% | 5048 |
|
|
2025
Q2 | $168K | Buy |
23,076
+17,524
| +316% | +$141K | ﹤0.01% | 4695 |
|
|
2025
Q1 | $52K | Buy |
+5,552
| New | +$69.3K | ﹤0.01% | 5733 |
|
|
2023
Q4 | – | Sell |
-16,207
| Closed | -$265K | – | 9465 |
|
|
2023
Q3 | $199K | Buy |
+16,207
| New | +$241K | ﹤0.01% | 4363 |
|
|
2022
Q4 | – | Sell |
-1,910
| Closed | -$17.8K | – | 9974 |
|
|
2022
Q3 | $16K | Sell |
1,910
-5,085
| -73% | -$50.5K | ﹤0.01% | 7762 |
|
|
2022
Q2 | $57K | Sell |
6,995
-15,446
| -69% | -$147K | ﹤0.01% | 6314 |
|
|
2022
Q1 | $272K | Buy |
22,441
+17,163
| +325% | +$361K | ﹤0.01% | 4685 |
|
|
2021
Q4 | $180K | Buy |
5,278
+2,742
| +108% | +$107K | ﹤0.01% | 5343 |
|
|
2021
Q3 | $113K | Buy |
2,536
+100
| +4% | +$4.63K | ﹤0.01% | 6449 |
|
|
2021
Q2 | $110K | Sell |
2,436
-5,932
| -71% | -$263K | ﹤0.01% | 6593 |
|
|
2021
Q1 | $0 | Sell |
8,368
-7,999
| -49% | -$416K | ﹤0.01% | 9626 |
|
|
2020
Q4 | $881K | Buy |
16,367
+15,663
| +2,225% | +$708K | ﹤0.01% | 2725 |
|
|
2020
Q3 | $25K | Sell |
704
-564
| -44% | -$21K | ﹤0.01% | 6219 |
|
|
2020
Q2 | $39K | Sell |
1,268
-7,648
| -86% | -$212K | ﹤0.01% | 5699 |
|
|
2020
Q1 | $246K | Buy |
8,916
+4,889
| +121% | +$146K | ﹤0.01% | 3350 |
|
|
2019
Q4 | $117K | Sell |
4,027
-7,487
| -65% | -$178K | ﹤0.01% | 4350 |
|
|
2019
Q3 | $220K | Buy |
+11,514
| New | +$270K | ﹤0.01% | 3460 |
|
|
2019
Q2 | – | Sell |
-1,211
| Closed | -$26.6K | – | 7537 |
|
|
2019
Q1 | $24K | Buy |
+1,211
| New | +$21K | ﹤0.01% | 5595 |
|
|
2018
Q4 | – | Sell |
-19,418
| Closed | -$289K | – | 7539 |
|
|
2018
Q3 | $298K | Buy |
+19,418
| New | +$268K | ﹤0.01% | 3189 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$1.1K | – | 7715 |
|
|
2018
Q1 | $0 | Buy |
+100
| New | +$810 | ﹤0.01% | 6610 |
|
|
2017
Q4 | – | Sell |
-67
| Closed | – | – | 6428 |
|
|
2017
Q3 | $0 | Buy |
+67
| New | +$652 | ﹤0.01% | 6369 |
|
|
2016
Q3 | – | Sell |
-125
| Closed | -$1.05K | – | 6230 |
|
|
2016
Q2 | $1K | Buy |
+125
| New | +$1K | ﹤0.01% | 5359 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Simplex Trading's NEO Position: Q2 2026 in Review
Simplex Trading increased its NeoGenomics (NEO) stake by 624% in Q2 2026, buying an estimated $454K and bringing the position to 54,589 shares worth $796K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.
Simplex Trading first reported a position in NEO in Q2 2016 and has held it in 25 quarters since. The position peaked at $881K in Q4 2020. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Simplex Trading held 54,589 shares of NeoGenomics worth $796K as of Q2 2026.
- Simplex Trading bought 47,053 NeoGenomics shares in Q2 2026, an estimated $454K.
- NeoGenomics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3031 holding.
- Simplex Trading first reported a position in NeoGenomics in Q2 2016 and has held it in 25 quarters since.
- Simplex Trading's NeoGenomics position peaked at $881K in Q4 2020.
- 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.